AEON Biopharma, Inc.
AEON Biopharma, Inc. (AEON) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 15 transactions totaling $73.8M, demonstrating a bearish sentiment with -$73.8M in net insider flow. The most recent transaction on Feb 17, 2026 involved a transaction of 3,000,000 shares valued at $0.
AEON Insider Activity Summary
Who Is Buying AEON Stock?
No significant insider buying has been recorded for AEON in the recent period.
Who Is Selling AEON Stock?
No significant insider selling has been recorded for AEON in the recent period.
Is AEON Biopharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AEON is bearish with an Insider Alignment Score of 0/100 and a net flow of -$73.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
AEON Frequently Asked Questions
Understanding AEON Insider Activity
Insider trading at AEON Biopharma, Inc. (AEON) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading AEON stock, having executed 15 transactions in the past 90 days. The most active insider is Crown Holdings Group, Llc Strathspey (Executive), who has made 1 transactions totaling $73.8M.
Related Tools
Track AEON Biopharma, Inc. Insider Activity
Get notified when executives and directors at AEON file new Form 4 transactions